A Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study

Clinical trial NCT00096967 · COMPLETED

Trial details

NCT number: NCT00096967
Sponsor: Genentech, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Cancer Colorectal Cancer Metastases

Start date: 2002-10-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.